|

ABP-671 plus allopurinol Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Atom Therapeutics Co., Ltd1

Indications

  • DDI (Drug-Drug Interaction)1
  • Gout Chronic1
  • Gout1
  • Arthritis1

Cary, North Carolina1 trial

Drug-Drug Interaction Study of ABP-671 in Gout Patients

Wakefield Clinical Research

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.